HDCN Online Slide/Audio Symposium    
American Society of Nephrology

Genzyme Therapeutics

Satellite Symposium of the American Society of Nephrology 31st Annual Scientific Meeting, October, 1998
Genzyme Therapeutics, ASN Corporate Sponsor
Supported by an unrestricted grant from Genzyme Therapeutics

Hyperphosphatemia: Clinical Complications and Management in 1998
You need to REGISTER WITH HDCN (it's free) before you can access these talks. This program offers 1.5 hours of Category One CME Credit through the University of Minnesota. For CME-related information click here
The Talks

Introductory Remarks
Eduardo Slatopolsky, M.D.

Overview of Hyperphosphatemia
Francisco Llach, M.D.

Current Tools in Phosphate Management
Jill Lindberg, M.D.

New Therapeutic Approaches in the Treatment of Hyperphosphatemia
Eduardo Slatopolsky, M.D.

Questions and Answers
Drs. Lindberg, Llach, and Slatopolsky

Selected References
Compiled by course faculty


Jill Lindberg, M.D., Professor of Medicine, Director of Nephrology Research an Chronic Hemodialysis, Co-Director of the Metabolic Bone & Stone Clinic, Ochsner Clinic, New Orleans, LA

Francisco Llach, M.D., Professor of Medicine, Chief of Nephrology, Beth Israel Medical Center, Newark, NJ

Eduardo Slatopolsky, M.D., Professor of Renal Diseases in Medicine, Washington University, St. Louis, MO

Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page